Boswellia papyrifera
Boswellia papyrifera · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Boswellia papyrifera is a notable plant species known for its medicinal potential derived primarily from its stem and resins. Research has focused on its chemical constituents, specifically highlighting the presence of boswellic acid and piperitone. Various preparations, such as crude methanol extracts, defatted methanol extracts, and resins, are utilized to study its bioactive properties. These substances are being investigated for their efficacy against specific conditions, including Madurella mycetomatis and Multiple Sclerosis. Through these diverse extracts, the plant continues to serve as a vital subject in pharmacological studies.
- Synonyms
- Ploesslea Floribunda · Amyris Papyrifera · 4 more
- Common names
- Not available
- Family
- Burseraceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Common Names
Boswellia papyrifera is a remarkable species known by several distinct common names across different cultures. In Sudan, it is frequently referred to as Sudanese frankincense, highlighting its valuable resinous properties. It is also widely recognized by the names elephant tree and elephant-tree, likely due to its unique physical appearance. In Chinese-speaking regions, the plant is identified as 紙皮乳香 or the more specific 紙皮乳香樹. These various designations reflect the widespread global recognition and cultural significance of this versatile tree.
Sources: Catalogue of Life (COL)
Synonyms
Boswellia papyrifera is a botanical species known for its complex taxonomic history and various scientific designations. Throughout different studies, this plant has been identified by several different names, including the synonym Amyris papyrifera. It has also been referred to in botanical literature as Boswellia chariensis and Boswellia floribunda. Furthermore, the species is linked to the synonyms Boswellia occidentalis and Boswellia odorata. Understanding these shifting relationships is essential for accurate classification and research within the genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Boswellia papyrifera is a unique species belonging to the kingdom Plantae. Within this vast biological group, it is classified under the class Equisetopsida. Its taxonomic journey continues through the order Sapindales, which helps define its evolutionary lineage. Furthermore, it is a member of the distinct genus Boswellia. Ultimately, this classification places the plant firmly within the aromatic family Burseraceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Burseraceae |
| Genus | Boswellia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Boswellia papyrifera is a significant species with a broad distribution spanning across various regions of the African continent. It is notably found within East Tropical Africa, including areas such as Uganda. The plant also thrives throughout Northeast Tropical Africa, establishing a presence in countries like Chad and Eritrea. Furthermore, its range extends into Ethiopia and the regions of Sudan and South Sudan. This widespread geographic footprint highlights the plant's adaptability to diverse African environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Boswellia papyrifera is a self-supporting tree that serves as a distinct feature of its native landscape. This species typically exhibits a robust growth form, allowing it to stand firmly without external support. While the height of individual specimens can vary significantly, they generally reach a minimum of 8 meters. Some smaller trees may start at a lower threshold of approximately 3.66 meters. Ultimately, these trees can reach a maximum height of about 12.19 meters as they mature.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Boswellia papyrifera stands out as a significant medicinal plant used in the management of multiple sclerosis symptoms. This specific plant is a known source of boswellic acid, which serves as one of the primary bioactive components with therapeutic benefits. Clinical reviews suggest that such metabolites may help address various complications of the disorder, including spasticity and fatigue. While herbal medicines are generally well tolerated, researchers emphasize that these natural compounds offer promising potential for neurological care. Consequently, further large-scale human studies are recommended to fully confirm the clinical role of these plant-derived substances.
Conditions
Boswellia papyrifera serves as a medicinal plant with diverse therapeutic potential, including the management of multiple sclerosis symptoms. The plant exhibits significant antifungal activity against Madurella mycetomatis, making it a candidate for treating eumycetoma. It is also recognized for its anti-TB activity, providing a potential source for new tuberculosis drug discovery. Furthermore, the presence of the diterpene incensole in its resin contributes to potent anti-inflammatory and anti-depressant effects. These varied pharmacological properties highlight the importance of the species in addressing complex chronic inflammatory and neurological conditions.
Preparations
Boswellia papyrifera is prepared as crude methanol, hexane extracts, and defatted methanol extracts for pharmacological testing. These specific preparations, including the crude methanol extracts, have demonstrated significant antifungal activity against Madurella mycetomatis. Additionally, the plant is prepared as resins for use in traditional medicinal preparations. Research into these various forms of Boswellia papyrifera highlights their potential for developing novel therapeutic drugs.
Parts used
Boswellia papyrifera serves as a significant source of diverse bioactive constituents used in phytochemical research. Recent investigations have focused specifically on the chemical properties found within the plant's stem bark extract. Through this analysis, researchers identified several new stilbene glycosides and a unique triterpene. These extracted compounds, including various boswellic acids, demonstrate notable biological potential. Specifically, the stilbene glycosides show significant inhibition of phosphodiesterase I and xanthine oxidase.